Tag: Regulus Therapeutics

Gilead Sciences GILD NASDAQ:GILD
Finance

Biotech Bullish Stocks: Regulus Therapeutics Inc (NASDAQ:RGLS), Insys Therapeutics (NASDAQ:INSY), Repligen Corporation (NASDAQ:RGEN), Sarepta Therapeutics (NASDAQ:SRPT)

Shares of Regulus Therapeutics Inc (NASDAQ:RGLS) were the target of a significant decrease in short interest in January. As of March 14th, there was short interest totaling 1,460,571 shares, a decrease of 20.3% from the February 28th total of 1,832,140 shares, Analyst Ratings Newsreports. Regulus Therapeutics Inc (NASDAQ:RGLS) stock performance was 5.09% in last session and finished the day at $7.64. Traded volume was 161,836.00million … Continue reading Biotech Bullish Stocks: Regulus Therapeutics Inc (NASDAQ:RGLS), Insys Therapeutics (NASDAQ:INSY), Repligen Corporation (NASDAQ:RGEN), Sarepta Therapeutics (NASDAQ:SRPT)

Kevin Long
BioTech

Biotech Top Losers: TESARO Inc. (NASDAQ:TSRO), Dyax Corp. (NASDAQ:DYAX), Regulus Therapeutics (NASDAQ:RGLS), Cara Therapeutics (NASDAQ:CARA)

Tesaro Inc. (NASDAQ:TSRO) announced Thursday morning that it has entered into an exclusive, worldwide license agreement and immuno-oncology antibody collaboration with AnaptysBio Inc. TESARO Inc. (NASDAQ:TSRO) stock performance was -5.40% in last session and finished the day at $36.76. Traded volume was 732,104.00 shares in the last session and the average volume of the stock remained 469,070.00 shares. TESARO Inc. (NASDAQ:TSRO) insider ownership is 21.88%. … Continue reading Biotech Top Losers: TESARO Inc. (NASDAQ:TSRO), Dyax Corp. (NASDAQ:DYAX), Regulus Therapeutics (NASDAQ:RGLS), Cara Therapeutics (NASDAQ:CARA)

John Bellich